Stock 1720 STANDARD CHEMICAL & PHARMACEUTICAL CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Standard Chemical & Pharmaceutical Co. Ltd. Share Price

Equities

1720

TW0001720001

Pharmaceuticals

End-of-day quote Taiwan S.E.
Other stock markets
 03:30:00 24/05/2024 am IST 		5-day change 1st Jan Change
69.5 TWD -1.70% Intraday chart for Standard Chemical & Pharmaceutical Co. Ltd. +0.87% +5.46%
08/05 Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
01/03 Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Financials

Sales 2024 * 6.8B 211M 17.52B Sales 2025 * - Capitalization 12.42B 385M 31.99B
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.83 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * -
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 45.43%
More Fundamentals * Assessed data

Chart Standard Chemical & Pharmaceutical Co. Ltd.

Dynamic Chart

Latest news about Standard Chemical & Pharmaceutical Co. Ltd.

Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Announces Cash Dividend, Payable on August 31, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Appoints Lawrence C. Lee, Independent Director as Audit Committee Member, Effective June 20, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Elects One Additional Director and One Additional Independent Director CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Standard Chemical & Pharmaceutical Co. Ltd. Announces Executive Changes CI
Standard Chemical & Pharmaceutical Co. Ltd. Announces CFO Changes CI
Standard Chemical & Pharmaceutical Co. Ltd. Receives Resignation Letter from Chin-Tsai, Fan, the Chairman of the Board, Effective March 14, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Standard Chem & Pharm CO., LTD. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Standard Chem & Pharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news

Press releases Standard Chemical & Pharmaceutical Co. Ltd.

Standard Chem & Pharm : Announcement of the company’s board of directors agreeing to lift the prohibition on competition for manager PU
Standard Chem & Pharm : Announcement of the board approved of the 2022Q2 consolidated financial statements PU
Standard Chem & Pharm : Announcement of the resolution by the Company’s board of directors for the ex-dividend record date of cash dividends. PU
Standard Chem & Pharm : Announcement of resolution to release of the Board of Director from non-competition restrictions of the 2022 Annual S.C.P.C. Shareholders’Meeting PU
Standard Chem & Pharm : Announcement of important resolutions of the 2022 annual Standard Chem. and Pharm. Co., Ltd. shareholders’ Meeting PU
More press releases

Quotes and Performance

1 day-1.70%
1 week+0.87%
Current month+9.97%
1 month+11.56%
3 months+3.58%
6 months+9.28%
Current year+5.46%
More quotes

Highs and lows

1 week
69.20
Extreme 69.2
77.70
1 month
62.20
Extreme 62.2
77.70
Current year
60.50
Extreme 60.5
77.70
1 year
58.10
Extreme 58.1
79.60
3 years
36.80
Extreme 36.8
79.60
5 years
27.35
Extreme 27.35
79.60
10 years
24.10
Extreme 24.1
79.60
More quotes

Managers and Directors - Standard Chemical & Pharmaceutical Co. Ltd.

Managers TitleAgeSince
Tzu Ting Fan CEO
 Chief Executive Officer - 30/06/30
Reynold Hsu DFI
 Director of Finance/CFO - 16/19/16
Wei Jen Chen PRN
 Corporate Officer/Principal - 01/01/01
Members of the board TitleAgeSince
Chin Tsai Fan FOU
 Founder - 30/67/30
Tsui Wen Yeh BRD
 Director/Board Member - 29/02/29
Tzu Ting Fan CEO
 Chief Executive Officer - 30/06/30
More insiders

Quotes

Date Price Change Volume
24/24/24 69.5 -1.70% 712,195
23/24/23 70.7 +0.57% 981,837
22/24/22 70.3 -1.26% 1,223,153
21/24/21 71.2 +0.85% 1,293,559
20/24/20 70.6 -2.08% 3,709,185

End-of-day quote Taiwan S.E., May 24, 2024

More quotes

Company Profile

Standard Chem & Pharm Co Ltd is a Taiwan-based company principally engaged in the manufacture and sales of western pharmaceuticals, dietary supplement and active pharmaceutical ingredients. The Company’s products cover circulatory system drugs, digestive system drugs, respiratory system drugs, nervous system drugs, metabolic drugs and general foods and health foods. The Company is also engaged in the sales of medical equipment, animal medicine, cosmetics and milk powder. The Company's products are sold to domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
20/06/2024 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
69.5 TWD
Average target price
80 TWD
Spread / Average Target
+15.11%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
STANDARD CHEMICAL & PHARMACEUTICAL CO. LTD. Stock Standard Chemical & Pharmaceutical Co. Ltd.
+5.46% 392M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.51% 728B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+33.05% 603B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.23% 360B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.78% 332B
ABBVIE INC. Stock AbbVie Inc.
+1.35% 279B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.00% 244B
NOVARTIS AG Stock Novartis AG
+8.09% 207B
ROCHE HOLDING AG Stock Roche Holding AG
-5.77% 205B
AMGEN INC. Stock Amgen Inc.
+6.19% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 1720 Stock